Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor, prominently expressed in barrier tissues and organs. The functional diversity of AHR signaling in physiology stems primarily from ligand specificity and crosstalk with its protein partners. Its ability to sense chemically diverse cues underpins its emerging therapeutic potential in autoimmune and oncological disorders. Recent breakthroughs in structural biology have elucidated key aspects of AHR function and modulation, including its promiscuous ligand recognition, heterodimerization, DNA response element engagement, and ligand-dependent receptor activation, distinguishing it from other basic helix-loop-helix-PER-ARNT-SIM (bHLH-PAS) family members. In this review article, we discuss these advances, highlighting how high-resolution structural insights are redefining our mechanistic understanding of AHR and guiding strategies for its pharmacological modulation across diverse physiological and pathological contexts.

More information Original publication

DOI

10.1016/j.tibs.2026.02.018

Type

Journal article

Publication Date

2026-03-01T00:00:00+00:00

Addresses

S, t, a, t, e, , K, e, y, , L, a, b, o, r, a, t, o, r, y, , o, f, , M, i, c, r, o, b, i, a, l, , T, e, c, h, n, o, l, o, g, y, ,, , S, h, a, n, d, o, n, g, , U, n, i, v, e, r, s, i, t, y, ,, , Q, i, n, g, d, a, o, , 2, 6, 6, 2, 3, 7, ,, , C, h, i, n, a, .